AstraZeneca (AZN)

Add to Watchlists
Create an Alert
63.50 -0.03  -0.05% NYSE Apr 17, 4:59PM BATS Real time Currency in USD

AstraZeneca Revenue (TTM):

25.71B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

AstraZeneca Revenue (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Revenue (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 25.71B
Sept. 30, 2013 26.15B
June 30, 2013 26.58B
March 31, 2013 27.01B
Dec. 31, 2012 27.97B
Sept. 30, 2012 29.35B
June 30, 2012 30.88B
March 31, 2012 32.65B
Dec. 31, 2011 33.59B
Sept. 30, 2011 33.55B
June 30, 2011 33.24B
March 31, 2011 32.98B
Dec. 31, 2010 33.27B
Sept. 30, 2010 33.60B
June 30, 2010 33.90B
March 31, 2010 33.68B
Dec. 31, 2009 32.80B
Sept. 30, 2009 32.05B
June 30, 2009 31.63B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Get data for
Advertisement

AZN Revenue (TTM) Benchmarks

Companies
GlaxoSmithKline 41.76B
Pfizer 52.67B
Johnson & Johnson 71.31B

AZN Revenue (TTM) Range, Past 5 Years

Minimum 25.71B Dec 2013
Maximum 33.90B Jun 2010
Average 31.08B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.